Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO

Abstract Background Disease-modifying drug use necessitates better Alzheimer disease (AD) detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk group; similarly, mild behavioral impairment (MBI) leverages behavioral change. Adding MBI to MCI improves dementia pr...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zahinoor Ismail, Rebeca Leon, Byron Creese, Clive Ballard, Philippe Robert, Eric E. Smith
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2023-07-01
Edice:	Molecular Neurodegeneration
Témata:	Alzheimer’s disease Mild cognitive impairment Prodromal disease Neuropsychiatric symptoms Mild behavioral impairment Biomarkers
On-line přístup:	https://doi.org/10.1186/s13024-023-00631-6
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!